Signal transduction mechanisms and behavioral sensitization to stimulant drugs: An overview of camp and pla2

Journal of Addictive Diseases

Volumn 20, Issue 3, 2001, Pages 33-42

  Gelowitz, Douglas L ^a   Berger, S Paul ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Amphetamine; Behavioral sensitization; Camp; Cocaine; Craving; Drug addiction; PLA2; Signal transduction; Stimulants

Indexed keywords

CENTRAL STIMULANT AGENT; CYCLIC AMP; PHOSPHOLIPASE A2;

BEHAVIOR; DOPAMINERGIC NERVE CELL; DRUG DEPENDENCE; HUMAN; LIMBIC SYSTEM; NEUROTRANSMISSION; NUCLEUS ACCUMBENS; REVIEW; SECOND MESSENGER; SENSITIZATION; SIGNAL TRANSDUCTION; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM; CYCLIC AMP; PHOSPHOLIPASES A; SIGNAL TRANSDUCTION;

EID: 0035187197     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v20n03_04     Document Type: Article

References (61)

1. Gelowitz, DL, Kokkinidis, L. The effects of amygdaloid stimulation on amphetamine-elicited locomotor sensitization. Brain Res Bull 1993; 32: 561-5.
2. Kalivas, PW, Stewart, J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 1991; 16: 223-44.
3. Pierce, RC, Kalivas, PW. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997; 25: 192-216.
4. Robinson, TE, Becker, JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986; 396: 157-98.
5. Karler, R, Calder, LD, Chaudhry, IA, Turkanis, SA. Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801. Life Sci 1989; 45: 599-606.
6. Wolf, ME. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 1998; 54: 679-720.
7. Koob, GF, Le Moal, M. Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52-8.
8. Koob, GF, Nestler, EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997; 9: 482-97.
9. Nestler, EJ, Aghajanian, GK. Molecular and cellular basis of addiction. Science 1997; 278: 58-63.
10. Reid, MS, Hsu, K, Tolliver, BK, Crawford, CA, Berger, SP. Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization. J Pharmacol Exp Ther 1996; 276: 1244-56.
11. Robinson, TE, Kolb, B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 1997; 17: 8491-7.
12. Self, DW, Nestler, EJ. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend 1998; 51: 49-60.
13. Steketee, JD, Kalivas, PW. Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J Pharmacol Exp Ther. 1991; 259 (2): 916-24.
14. Tolliver, BK, Ho, LB, Fox, LM, Berger, SP. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine. J Pharmacol Exp Ther 1999; 289: 38-47.
15. Tolliver, BK, Ho, LB, Reid, MS, Berger, SP. Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants. J Pharmacol Exp Ther 1996; 278: 411-20.
16. Berger, SP, Hall, S, Mickalian, JD, Reid, MS, Crawford, CA, Delucchi, K, Carr, K. Haloperidol antagonism of cue-elicited cocaine craving. Lancet 1996; 347: 504-8.
17. Kalivas, PW, Pierce, RC, Cornish, J, Sorg, BA. A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol 1998; 12: 49-53.
18. Robinson, TE, Berridge, KC. The neural basis of drug craving: an incen- tive-sensitization theory of addiction. Brain Res Brain Res Rev 1993; 18: 247-91.
19. Atre-Vaidya, N, Taylor, MA. The sensitization hypothesis and importance of psychosensory features in mood disorder: a review. J Neuropsychiatry Clin Neurosci 1997; 9: 525-33.
20. Duncan, GE, Sheitman, BB, Lieberman, JA. An integrated view of pathophysiological models of schizophrenia. Brain Res Brain Res Rev 1999; 29: 250-64.
21. Fritze, J, Schneider, B, Maurer, K. Additive effects, but no synergistic interaction of stressful life-events and genetic loading in affective disorders. JNeural Transm 1996; 103: 1221-9.
22. Glenthoj, BY, Hemmingsen, R. Dopaminergic sensitization: implications for the pathogenesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21: 23-46.
23. Hammen, C, Gitlin, M. Stress reactivity in bipolar patients and its relation to prior history of disorder. Am J Psychiatry 1997; 154: 856-7.
24. Lieberman, JA, Sheitman, BB, Kinon, BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997; 17: 205-29.
25. Post, RM, Weiss, SR. Sensitization, kindling, and anticonvulsants in mania. J Clin Psychiatry 1989; 50 Suppl: 23-30; discussion 45-7.
26. Post, RM. Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry 1990; 23: 3-17.
27. Sato, M, Numachi, Y, Hamamura, T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992a; 18: 115-22.
28. Sato, M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci 1992b; 654: 160-70.
29. Strakowski, SM, Sax, KW, Setters, MJ, Stanton, SP, Keck, PE, Jr. Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitization model of psychosis in humans. Biol Psychiatry 1997; 42: 749-55.
30. Kuczenski, R, Segal, DS. Sensitization of amphetamine-induced stereotyped behaviors during the acute response. J Pharmacol Exp Ther 1999a; 288: 699-709.
31. Strakowski, SM, Sax, KW. Progressive behavioral response to repeated d-am- phetamine challenge: further evidence for sensitization in humans. Biol Psychiatry 1998; 44: 1171-7.
32. Strakowski, SM, Sax, KW, Setters, MJ, Keck, PE, Jr. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry 1996; 40: 872-80.
33. Coghlan, VM, Perrino, BA, Howard, M, Langeberg, LK, Hicks, JB, Gallatin, WM, Scott, JD. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 1995; 267: 108-11.
34. Hunter, T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995; 80: 225-36.
35. Nestler, EJ, Greengard, P. Neuron-specific phosphoproteins in mammalian brain. Adv Cyclic Nucleotide Protein Phosphorylation Res 1984; 17: 483-8.
36. Miserendino, MJ, Nestler, EJ. Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res 1995; 674: 299-306.
37. Ortiz, J, DeCaprio, JL, Kosten, TA, Nestler, EJ. Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area. Neuroscience 1995; 67: 383-97.
38. Schoffelmeer, AN, Voorn, P, Jonker, AJ, Wardeh, G, Nestby, P, Vanderschuren, LJ, De Vries, TJ, Mulder, AH, Tjon, GH. Morphine-induced increase in D-1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: possible role in behavioral sensitization. NeurochemRes 1996; 21: 1417-23.
39. Terwilliger, RZ, Beitner-Johnson, D, Sevarino, KA, Crain, SM, Nestler, EJ. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 1991; 548: 100-10.
40. Unterwald, EM, Fillmore, J, Kreek, MJ. Chronic repeated cocaine administration increases dopamine D1 receptor-mediated signal transduction. Eur J Pharmacol 1996; 318: 31-5.
41. Beyer, CE, Steketee, JD. Dopamine depletion in the medial prefrontal cortex induces sensitized-like behavioral and neurochemical responses to cocaine. Brain Res 1999; 833: 133-41.
42. Kuczenski, R, Segal, DS. Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors. Brain Res 1999b; 822: 164-74.
43. Cunningham, ST, Kelley, AE. Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens. J Neurosci 1993; 13: 2342-50.
44. Stewart, J, Vezina, P. Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res 1989; 495: 401-6.
45. Byrnes, JJ, Weinstein, DM, Wallace, LJ. Robust sensitization to amphetamine following intra-VTA cholera toxin administration. Synapse 1997; 25 (4): 335-44.
46. Ozawa, T, Nakagawa, T, Minami, M, Satoh, M. Supersensitization of the adenylyl cyclase system in Chinese hamster ovary cells co-expressing cloned opioid receptors and Gz, a PTX-insensitive G protein. Neurosci Lett. 1999; 267 (2): 117-20.
47. Mayer, RJ, Marshall, LA. New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and non-selective enzymes. Faseb J 1993; 7: 339-48.
48. Catania, MV, Hollingsworth, Z, Penney, JB, Young, AB. Phospholipase A2 modulates different subtypes of excitatory amino acid receptors: autoradiographic evidence. J Neurochem 1993; 60: 236-45.
49. Desnos, C, Laran, MP, Scherman, D. Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells: stimulus-biosynthesis coupling. J Neurochem 1992; 59: 2105-12.
50. Koltai, M, Hosford, D, Guinot, P, Esanu, A, Braquet, P. PAF. A review of its effects, antagonists and possible future clinical implications (Part II). Drugs 1991; 42: 174-204.
51. Lynch, MA, Voss, KL, Rodriguez, J, Bliss, TV. Increase in synaptic vesicle proteins accompanies long-term potentiation in the dentate gyrus. Neuroscience 1994; 60: 1-5.
52. Overton, PG, Richards, CD, Berry MS, Clark, D. Long-term potentiation at excitatory amino acid synapes onmidbrain dopamine neurons. Neuroreport 1999; 10 (2): 221-6.
53. Schacher, S, Kandel, ER, Montarolo, P. cAMP and arachidonic acid simulate long-term structural and functional changes produced by neurotransmitters in Aplysia sensory neurons. Neuron 1993; 10: 1079-88.
54. Karler, R, Finnegan, KT, Calder, LD. Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Res 1993; 603: 19-24.
55. Sarvey, JM, Burgard, EC, Decker, G. Long-term potentiation: studies in the hippocampal slice. J Neurosci Methods 1989; 28: 109-24.
56. Lister, MD, Glaser, KB, Ulevitch, RJ, Dennis, EA. Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5, 8-eicosadienoic acid, andp-bromophenacylbromide. J BiolChem 1989; 264: 8520-8.
57. Balsinde, J, Dennis, EA. Function and inhibition of intracellular calcium-independent phospholipase A2. J Biol Chem 1997; 272: 16069-72.
58. Kimura, M, Kimura, I, Shikada, A, Takahashi, K. Calcium-dependent regulation of phospholipase A2 and its inhibitors, including tetracaine, for acetylcholine receptor cluster formation in mouse myotubes co-cultured with spinal cord explant. Int J Dev Neurosci. 1987; 5 (2): 127-33.
59. Wolf, MJ, Izumi, Y, Zorumski, CF, Gross, RW. Long-term potentiation requires activation of calcium-independent phospholipase A2. FEBS Lett 1995; 377: 358-62.
60. Ross, BM, Moszczynska, A, Kalasinsky, K, Kish, SJ. Phospholipase A2 activity is selectively decreased in the striatum of chronic cocaine users. J Neurochem 1996; 67: 2620-3.
61. Kovacs, P, Csaba, G. PLA2 activity in Tetrahymena pyriformis. Effects of inhibitors and stimulators. J Lipid Mediat Cell Signal. 1997; 15 (3): 233-47.